Mergers & Acquisitions ·
On August 21, 2026, Rik Deitsch transferred twelve million shares of Series B Preferred Stock to Pure Raw Supplies…
NPHCNutra Pharma Corp
On August 21, 2026, Rik Deitsch transferred twelve million shares of Series B Preferred Stock to Pure Raw Supplies, LLC without consideration. The preferred stock carries supermajority voting rights sufficient to control substantially all matters submitted to stockholders. Consequently, a change in control occurred on that date, with Pure Raw Supplies, LLC becoming the controlling stockholder and holding 62.63% of the total voting power, previously held by Deitsch. Nutra Pharma Corp. operates in the pharmaceutical industry.